"Digestive Disease Medicine of Central New York (DDM) is a high-quality, individualized gastroenterology practice that has been serving patients in Central New York for over 35 years. . Our team of specialists and staff strive to improve our patients’ overall health by focusing on preventing, diagnosing, and treating conditions associated with your digestive system. The DDM team includes seven physicians who are all board-certified in Internal Medicine and Gastroenterology by the American Board of Internal Medicine, along with eight nurse practitioners and physicians assistants, who are similarly boarded by their respective societies. We aspire to provide the highest quality digestive care in the region to our patients."

During the past decade, Digestive Disease Medicine Of Central New York conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Digestive Disease Medicine Of Central New York" #1 collaborator was "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Digestive Disease Medicine Of Central New York" are "Colitis, Ulcerative" (1 trials), "Colorectal Cancer" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Digestive Disease Medicine Of Central New York" in a lesser frequency.

Most popular intervention types in "Digestive Disease Medicine Of Central New York" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Duodenal Mucosal Resurfacing (DMR)" (1 trials), "Duodenal Mucosal Resurfacing (Sham)" (1 trials) and "Ozanimod" (1 trials). Other intervention names were less common.

The vast majority of trials in "Digestive Disease Medicine Of Central New York" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Digestive Disease Medicine Of Central New York". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Digestive Disease Medicine Of Central New York, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Digestive Disease Medicine Of Central New York, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".